The expected number of 14 randomised patients was exceeded in Phase III Peripheral Artery Disease clinical tail in Republican Panevezys Hospital and there are already 17 patients randomised
Phase II Beast Cancer oncological study was successfully completed in all three sites in Lithuania. One site (the National Cancer Institute) has contributed to 20% of all enrollment in Europe.
1 patient has been randomised in Phase III Oncological Study conducted in Republican Panevezys Hospital
1 patient has been randomised in Osteoarthritis Phase II study in Alytus District S. Kudirkos Hospital
ProAktis is a Clinical Research Management Organization (CRMO) which manages administration of clinical trials conduct at public, municipal and private health care institutions in Lithuania as well as Belarus and Russia
We increase the efficiency in management of clinical trials via establishment of a single point of contact.
One contact for Sponsors, CROs, and Health Care Institutions.
Focus on separation of research and administrative work of clinical trials by allowing professionals to do what they can do best